Collaboration between CeGaT and Amplexa

CeGaT and Amplexa (Denmark) will collaborate on diagnostic gene tests. Please see our joint press release.

Finalist of the CLARITY Challenge

CeGaT is thrilled that it is awarded finalist (Top 3) in the Clarity Challenge together with its partner Genomatix. Further information please visit the Note in Nature Medicine.

CeGaT starts FREE Exomes Project

To celebrate its successful participation in Boston Children’s Hospital Clarity Challenge, CeGaT together with Genomatix offers a free sequencing and analysis of 18 exomes: Each applicant is entitled to a maximum of three free exomes. Each applicant needs to complete the attached application form and needs to send it to info[at] All applications reaching us […]

CeGaT achieves 2nd place at Deloittes Fast 50 competition

With a total growth of more than 3,200% in the last three years, CeGaT was awarded the 2nd place in the Rising-Stars category of Deloittes Fast 50 competition. With this award Deloitte honours the 50 fastest growing companies in Germany.

New subpanels for NMD, CMT, and Long QT

CeGaT now offers nine new subpanels for neuromuscular diseases, Charcot-Marie-Tooth, and long QT-syndrome. For further information please visit our Neurodegenerative Diseases section.